The patent pending (US and UK) HIPS® technology is a method using a practical approach, applying both chemistry and technology for complete facility disinfection. Annihilare CEO Marty Paris explains "our system provides unmatched results in disinfection by using the most effective fluids with the most effective cleaning protocol technology. DRM has a wide reach in the healthcare space, and we have a lot of confidence with this partnership."

HIPS® is the most innovative solution on the market today for dealing with Healthcare Associated Infections (HAIs) in all healthcare environments. The system, which produces 500ppm Hypochlorous acid (HOCl) that has an efficacy rate of up to 99.9999% for all current environmental contributing HAIs. HOCl is made from naturally occurring elements, is generated at a pH range of 6.0 to 7.0, and is Green Seal® certified. DRM President, George Morrison, said "HIPS is the most innovative solution that we have found. HIPS is an industry disruptor, and we are very excited about this partnership."